Literature DB >> 27221867

Adenosine Deaminase - a Novel Diagnostic and Prognostic Biomarker for Oral Squamous Cell Carcinoma.

Deepak Chandrakant Kelgandre1, Jigna Pathak, Shilpa Patel, Pramod Ingale, Niharika Swain.   

Abstract

BACKGROUND: The number of patients with oral cancer in India is increasing gradually (especially in younger people). Although the diagnostic modalities and therapeutic management of oral cancer are improving, the treatment outcome and prognosis of oral cancer remain poor. The absence of definite early warning symptoms for most head and neck cancers suggests that sensitive and specific biomarkers are likely to be important in screening for high-risk patients. AIMS: To analyze serum adenosine deaminase (ADA) levels in oral squamous cell carcinoma (OSCC) cases who reported to our institute.
MATERIALS AND METHODS: A prospective study was performed on 100 histopathologically proven cases of OSCC (study group) and 100 normal healthy individuals (control group). Independent sample and one sample t-tests and one way ANOVA followed by Tuckey's POST HOC test were conducted for analysis.
RESULTS: Statistically significant increase in serum ADA levels was observed in OSCC cases compared to the control group. Also serum ADA level increased significantly with the histopathological grade.
CONCLUSIONS: Serum ADA levels in OSCC may be a useful diagnostic and prognostic biomarkers in clinical practice and our findings suggest that a large-scale study is warranted to confirm clinical utility as a prognostic and diagnostic biomarker.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27221867     DOI: 10.7314/apjcp.2016.17.4.1865

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  7 in total

1.  Serum Adenosine Deaminase Levels and Human Papillomavirus as Prognostic and Predictive Factors for Laryngeal and Pharyngeal Carcinomas.

Authors:  C Chandrakiran; Thanu Jogy; Sanjay B Patil
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-30

2.  Twenty‑four signature genes predict the prognosis of oral squamous cell carcinoma with high accuracy and repeatability.

Authors:  Jianyong Gao; Gang Tian; Xu Han; Qiang Zhu
Journal:  Mol Med Rep       Date:  2017-12-12       Impact factor: 2.952

3.  Increased Cytokeratin 19 Fragment Levels Are Positively Correlated with Adenosine Deaminase Activity in Malignant Pleural Effusions from Adenocarcinomas.

Authors:  Jorge Luiz Barillo; Cyro Teixeira da Silva Junior; Patricia Siqueira Silva; Joeber Bernardo Soares de Souza; Salim Kanaan; Analucia Rampazzo Xavier; Elizabeth Giestal de Araujo
Journal:  Dis Markers       Date:  2018-05-08       Impact factor: 3.434

4.  Changes of adenosine deaminase activity in serum and saliva around parturition in sows with and without postpartum dysgalactia syndrome.

Authors:  Marianne Kaiser; Jan Dahl; Stine Jacobsen; Magdalena Jacobson; Pia Haubro Andersen; Poul Bækbo; Damián Escribano; José Joaquín Cerón; Fernando Tecles
Journal:  BMC Vet Res       Date:  2021-11-18       Impact factor: 2.741

5.  Identification of an Immune Classification and Prognostic Genes for Lung Adenocarcinoma Based on Immune Cell Signatures.

Authors:  Lili Deng; Fei Long; Ting Wang; Ling Dai; Huajian Chen; Yujun Yang; Guoming Xie
Journal:  Front Med (Lausanne)       Date:  2022-03-30

6.  Adenosine Deaminase is a Potential Molecular Marker for Diagnosis and Prognosis of Haemorrhagic Fever with Renal Syndrome.

Authors:  Xiaoli Zhu; Jinxi Hu
Journal:  Infect Drug Resist       Date:  2022-09-05       Impact factor: 4.177

7.  Plasma Adenosine Deaminase (ADA)-1 and -2 Demonstrate Robust Ontogeny Across the First Four Months of Human Life.

Authors:  Oludare A Odumade; Alec L Plotkin; Jensen Pak; Olubukola T Idoko; Matthew A Pettengill; Tobias R Kollmann; Al Ozonoff; Beate Kampmann; Ofer Levy; Kinga K Smolen
Journal:  Front Immunol       Date:  2021-05-27       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.